DNA-based Skin Care Market Projected to Gain Significant Value through 2032

In the forecast period of 2022 to 2032, the global DNA-based skin care market is expected to grow at a CAGR of 5.3%. It is projected to grow steadily, reaching $4.7 billion in 2022 and $8.2 billion in 2032. Rising consumer spending is expected to accelerate the beauty and personal care industry, driving sales of DNA-based skin care products.

DNA-based skin care is the formulation and development of personalised skin care products based on patients' DNA. It entails obtaining DNA from a cheek swab and analysing it to determine the skin's inherent condition in terms of sun protection, collagen formation, antioxidant, glycation, and inflammation.

Increased spending on health and wellness products, as well as ongoing advances in genomics, are expected to benefit the market. Another factor driving the market is the inherent desire to look young, particularly among the geriatric population.

The growing influence of social media, lower prices for genetic diagnostics, and the expansion of the tourism industry are all expected to fuel the market. Furthermore, rising investments in the development of personalised medicines for the skin by numerous renowned as well as start-up companies are expected to accelerate the market.

CureSkin, a Bengaluru-based artificial intelligence-driven skin care and beauty brand, for example, successfully raised US$ 5 million in funding from JSW Ventures in March 2022. With this funding, the company hopes to expand into adjacent categories and increase its customer base. As new players enter the market and increase their investments, the market is expected to grow.

DNA-Based Skin Care Market: Market Participants

  • ALLÉL
  • IMAGENE LABS
  • Genetic Beauty
  • DNA Skin Institute
  • EpigenCare
  • ANAKE
  • Caligenix
  • LifeNome
  • SKINSHIFT
  • SkinDNA

Browse More@ https://www.futuremarketinsights.com/reports/dna-based-skin-care-market

Key Segments Profiled in the DNA-Based Skin Care Industry Survey

By Product Type:

  • Serums
  • Creams
  • Others

By Distribution Channel:

  • Offline
  • Online

By End Use:

  • Home User
  • Wellness Clinics
  • Salons

Comments

Post a Comment

Popular posts from this blog

Handheld Ultrasound Scanners Market Will Generate Booming Growth Opportunities to 2032

Image
According to industry predictions, the global Handheld Ultrasound Scanners Market Demand will increase at a CAGR of 9.1% from 2022 to 2032, reaching a value of US$ 472.1 million by the end of 2022. By 2032, sales are estimated to exceed a valuation of roughly US$ 1.1 billion. With an expected 83.6% market share in 2021, the wired modality now leads the sector. Because they connect to Bluetooth or Wi-Fi devices such as mobile phones or tablets, Handheld Ultrasound Scanners are gaining appeal among both medical professionals and non-radiologists. These devices improve networking systems and ease picture transfer to medical facilities. Global Handheld Ultrasound Scanners Market: Dynamics         Technological advancements in medical imaging devices, increased use of Handheld Ultrasound Scanners among non-radiologists, benefits from international trade agreements, increased importing of imaging diagnostics systems, increased use of Handheld Ultrasound Scanners in emergency medical service
Read more

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

Antidiabetics Market to reach US$ 223 billion by 2032, growing at a 9.6% CAGR from 2022 to 2032 | Future Market Insights, Inc.

Image
The global Antidiabetics Market is expected to earn US$ 223 billion while expanding at a CAGR of 9.6% during the forecast period. The rising prevalence of diabetes worldwide can be attributed to the market's expansion. The ageing baby boomer population is another factor driving the market during the forecast period. According to the International Diabetes Federation, the global diabetes incidence will increase from 366 million in 2011 to 552 million by 2030. During the forecast period, the industry is expected to benefit from a significant increase in the number of diabetic patients. Furthermore, new product development is expected to benefit the market in the near future. For example, Novo Nordisk, a Danish pharmaceutical company, announced the launch of oral semaglutide for the treatment of Type 2 diabetes in India in January 2022. Furthermore, the development of advanced pumps based on smart technologies like AI and ML is expected to open up a slew of new doors. For exampl
Read more